Difference between revisions of "Interferon alfa-2b (Intron-A)"
m |
|||
Line 1: | Line 1: | ||
− | |||
− | |||
==General information== | ==General information== | ||
Class/mechanism: Immune system activator; binds to cell surface receptors that modulate many downstream intracellular signal transduction pathways. Mechanism not fully understood.<ref name="insert">[http://www.spfiles.com/piintrona.pdf Interferon alfa-2b (Intron-A) package insert]</ref><ref>[[Media:Interferonalfa-2b.pdf | Interferon alfa-2b (Intron-A) package insert (locally hosted backup)]]</ref><ref>[http://www.introna.com Intron-A manufacturer's website]</ref> | Class/mechanism: Immune system activator; binds to cell surface receptors that modulate many downstream intracellular signal transduction pathways. Mechanism not fully understood.<ref name="insert">[http://www.spfiles.com/piintrona.pdf Interferon alfa-2b (Intron-A) package insert]</ref><ref>[[Media:Interferonalfa-2b.pdf | Interferon alfa-2b (Intron-A) package insert (locally hosted backup)]]</ref><ref>[http://www.introna.com Intron-A manufacturer's website]</ref> | ||
Line 9: | Line 7: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
+ | *[[Chronic myelogenous leukemia]] | ||
*[[Melanoma]] | *[[Melanoma]] | ||
*[[Multiple myeloma]] | *[[Multiple myeloma]] | ||
Line 17: | Line 16: | ||
*[http://chemocare.com/chemotherapy/drug-info/intron-a-interferon-alfa-2b.aspx Interferon alfa-2b (Intron-A) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/intron-a-interferon-alfa-2b.aspx Interferon alfa-2b (Intron-A) patient drug information (Chemocare)]</ref> | *[http://chemocare.com/chemotherapy/drug-info/intron-a-interferon-alfa-2b.aspx Interferon alfa-2b (Intron-A) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/intron-a-interferon-alfa-2b.aspx Interferon alfa-2b (Intron-A) patient drug information (Chemocare)]</ref> | ||
*[http://www.uptodate.com/contents/interferon-alfa-2b-patient-drug-information Interferon alfa-2b (Intron-A) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/interferon-alfa-2b-patient-drug-information Interferon alfa-2b (Intron-A) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/interferon-alfa-2b-patient-drug-information Interferon alfa-2b (Intron-A) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/interferon-alfa-2b-patient-drug-information Interferon alfa-2b (Intron-A) patient drug information (UpToDate)]</ref> | ||
+ | |||
+ | ==Also known as== | ||
+ | '''Caution, may also contain names for interferon beta, interferon gamma, or interferon alfa-2a.''' | ||
+ | |||
+ | {| border="1" style="text-align:center;" | ||
+ | !colspan="8" align="center" style="background-color:#0066FF"| '''Synonyms''' | ||
+ | |- | ||
+ | |Advaferon | ||
+ | |Alfaferone | ||
+ | |Berofor | ||
+ | |Biogamma | ||
+ | |Canferon A | ||
+ | |- | ||
+ | |Cytoferon | ||
+ | |Egiferon | ||
+ | |Feron | ||
+ | |Fiblaferon | ||
+ | |Frone | ||
+ | |- | ||
+ | |Finnferon-Alpha | ||
+ | |Heberon Alfa R | ||
+ | |Humoferon | ||
+ | |IFN Alpha | ||
+ | |Imufor | ||
+ | |- | ||
+ | |Imukin | ||
+ | |INF | ||
+ | |Inferax | ||
+ | |Infergen | ||
+ | |Inmutag | ||
+ | |- | ||
+ | |Interfero | ||
+ | |Interferon Alfanative | ||
+ | |Interferon Human | ||
+ | |Interferon Leucocyticum | ||
+ | |Interferon Lymphoblastoid | ||
+ | |- | ||
+ | |Interferonum Leucocyticum | ||
+ | |Laroferon | ||
+ | |Multiferon | ||
+ | |Namalvin | ||
+ | |OIF | ||
+ | |- | ||
+ | |Polyferon | ||
+ | |Realdiron | ||
+ | |Roceron-A | ||
+ | |Sumiferon | ||
+ | |Wellferon | ||
+ | |- | ||
+ | |} | ||
==References== | ==References== | ||
Line 22: | Line 71: | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
+ | |||
[[Category:Immunotherapy]] | [[Category:Immunotherapy]] | ||
+ | |||
+ | [[Category:Chronic myelogenous leukemia medications]] | ||
[[Category:Melanoma medications]] | [[Category:Melanoma medications]] | ||
[[Category:Multiple myeloma medications]] | [[Category:Multiple myeloma medications]] | ||
+ | [[Category:Neuroendocrine tumor medications]] | ||
[[Category:Transplant medications]] | [[Category:Transplant medications]] |
Revision as of 19:33, 8 September 2014
General information
Class/mechanism: Immune system activator; binds to cell surface receptors that modulate many downstream intracellular signal transduction pathways. Mechanism not fully understood.[1][2][3]
Route: SC, IM, IV, intralesional
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Chronic myelogenous leukemia
- Melanoma
- Multiple myeloma
- Neuroendocrine tumors
- Transplant conditioning regimens
Patient drug information
- Interferon alfa-2b (Intron-A) patient drug information (Chemocare)[4]
- Interferon alfa-2b (Intron-A) patient drug information (UpToDate)[5]
Also known as
Caution, may also contain names for interferon beta, interferon gamma, or interferon alfa-2a.
Synonyms | |||||||
---|---|---|---|---|---|---|---|
Advaferon | Alfaferone | Berofor | Biogamma | Canferon A | |||
Cytoferon | Egiferon | Feron | Fiblaferon | Frone | |||
Finnferon-Alpha | Heberon Alfa R | Humoferon | IFN Alpha | Imufor | |||
Imukin | INF | Inferax | Infergen | Inmutag | |||
Interfero | Interferon Alfanative | Interferon Human | Interferon Leucocyticum | Interferon Lymphoblastoid | |||
Interferonum Leucocyticum | Laroferon | Multiferon | Namalvin | OIF | |||
Polyferon | Realdiron | Roceron-A | Sumiferon | Wellferon |